Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial

Bibliographic Details
Main Authors:	Shih, Sophy TF, Davis-Lameloise, Nathalie, Janus, Edward D, Wildey, Carol, Versace, Vincent L, Hagger, Virginia, Asproloupos, Dino, O’Reilly, Sharleen, Phillips, Paddy A, Ackland, Michael, Skinner, Timothy, Oats, Jeremy, Carter, Rob, Best, James D, Dunbar, James A
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853589/

Similar Items

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: an update to the study protocol for a randomized controlled trial
by: Shih, Sophy TF, et al.
Published: (2014)

Mothers after Gestational Diabetes in Australia (MAGDA): A Randomised Controlled Trial of a Postnatal Diabetes Prevention Program
by: O’Reilly, Sharleen L., et al.
Published: (2016)

Implementation salvage experiences from the Melbourne diabetes prevention study
by: Dunbar, James, et al.
Published: (2012)

Results of the first recorded evaluation of a national gestational diabetes mellitus register: Challenges in screening, registration, and follow-up for diabetes risk.
by: Douglas I R Boyle, et al.

An interview with Dr. Magda Azab
Published: (2013)

Scaling-up from an implementation trial to state-wide coverage: results from the preliminary Melbourne Diabetes Prevention Study
by: Janus, Edward D, et al.
Published: (2012)

The Melbourne Diabetes Prevention Study (MDPS): study protocol for a randomized controlled trial
by: Davis-Lameloise, Nathalie, et al.
Published: (2013)

DPP4 in Diabetes
by: Röhrborn, Diana, et al.
Published: (2015)

A population-based observational study of diabetes during pregnancy in Victoria, Australia, 1999–2008
by: Abouzeid, Marian, et al.
Published: (2014)

Prevention of Diabetes after Gestational Diabetes: Better Translation of Nutrition and Lifestyle Messages Needed
by: O’Reilly, Sharleen L.
Published: (2014)

Nighttime Pc3 pulsations: MM100 and MAGDAS observations
by: Nadezda V. Yagova, et al.
Published: (2017-05-01)

Association of weight misperception with weight loss in a diabetes prevention program
by: Hernan, Andrea L, et al.
Published: (2014)

Occupational differences, cardiovascular risk factors and lifestyle habits in South Eastern rural Australia
by: Davis-Lameloise, Nathalie, et al.
Published: (2013)

Challenges of diabetes prevention in the real world: results and lessons from the Melbourne Diabetes Prevention Study
by: Dunbar, James A, et al.
Published: (2015)

Socio-Cultural Disparities in GDM Burden Differ by Maternal Age at First Delivery
by: Abouzeid, Marion, et al.
Published: (2015)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
by: Kishimoto, Miyako
Published: (2013)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
by: Gallwitz, Baptist
Published: (2013)

The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy
by: Dietrich, Nadine, et al.
Published: (2016)

Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
by: Vitale, Cristiana, et al.
Published: (2016)

DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
by: Kanazawa, Ippei, et al.
Published: (2014)

The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
by: Choe, Eun Yeong, et al.
Published: (2014)

Recruitment into diabetes prevention programs: what is the impact of errors in self-reported measures of obesity?
by: Hernan, Andrea, et al.
Published: (2012)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
by: Liu, Jinglong, et al.
Published: (2014)

Pretreatment, Psychological, and Behavioral Predictors of Weight Outcomes Among Lifestyle Intervention Participants in the Diabetes Prevention Program (DPP)
by: Delahanty, Linda M., et al.
Published: (2013)

DPP PERLU DITRANSFORMASI
by: MPRC, Pusat Media & Perhubungan Awam
Published: (2016)

Benefits galore from DPP
by: Jessica, Alexander
Published: (1988)

The Causes of Ante-Natal, Natal and Neo-Natal Mortality of Infants
Published: (1929)

Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
by: Evans, Marc, et al.
Published: (2015)

DPP DISARAN BAHAS USUL STRATEGIK
by: MPRC, Pusat Media & Perhubungan Awam
Published: (2017)

DPP‐4 inhibition and islet function
by: Ahrén, Bo
Published: (2011)

DPP: TOWARDS AN EFFICIENT USE OF RESOURCES
by: David, Nelson, et al.
Published: (1991)

DPP takes off with new technology
by: Donald, Harris
Published: (1987)

The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723–730
Published: (2013)

Letter: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)
by: Lee, Seung-Hwan
Published: (2014)

Response: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)
by: Choe, EunYeong, et al.
Published: (2014)

Prevention of Type 2 Diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project
by: Laatikainen, Tiina, et al.
Published: (2007)

Type 2 diabetes prevalence varies by socio-economic status within and between migrant groups: analysis and implications for Australia
by: Abouzeid, Marian, et al.
Published: (2013)

Association of DPP4 gene polymorphisms with type 2 diabetes mellitus in Malaysian subjects
by: Ahmed, R.H., et al.
Published: (2016)

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
by: Shirakawa, Jun, et al.
Published: (2011)

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
by: Lee, Jae-Geun, et al.
Published: (2011)